Levels and clinical significance of serum C1QC and VCAM-1 in patients with colorectal cancer or colorectal polyps/adenomas
Postgraduate Medical Journal · 24.05.2026 · 102 (1209) · 633-644
DOI: 10.1093/postmj/qgaf237 ↗Kurz gefasst
Fachartikel in der Zeitschrift Postgraduate Medical Journal, online erschienen am 09.01.2026. Verfasst von Chunbaixue Yang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Graduate College, Hebei North University, 11 Diamond South Road, Zhangjiakou 075000, Hebei Province, China. Hauptthemen laut MEDLINE: Vascular Cell Adhesion Molecule-1, Colorectal Neoplasms, Complement C1q, Adenoma. Die Arbeit nennt 35 Literaturangaben. Gefördert von: Hebei Province national college students innovation and entrepreneurship training project, Hebei North University Campus level Cultivation and Research Project, Graduate Innovation Funding Project in Hebei Province.
Abstract (Originalsprache)
Background
Colorectal cancer (CRC) screening is crucial for prevention. This study explored serum complement component 1q (C1QC) and vascular cell adhesion molecule-1 (VCAM-1) expression in CRC/polyp patients and their clinical significance for CRC diagnosis/staging.
Methods
Serum samples from 135 CRC patients, 135 polyp/adenoma patients, and 135 healthy controls (collected between 1 January 2023 and October 30 2023) were analyzed retrospectively. Data-independent acquisition proteomics identified differentially expressed proteins. C1QC and VCAM-1 levels were quantified via enzyme-linked immunosorbent assay. Diagnostic performance was evaluated via receiver operating characteristic curves and the area under the curve. Statistical analysis (SPSS 27.0, GraphPad Prism 9.5.1) included analysis of variance, Pearson correlation, and logistic regression (P < .05 was considered significant).
Results
C1QC and VCAM-1 levels were significantly greater in the CRC patient group than in the healthy/polyp group (P < .05), with no difference between the polyp and healthy groups (P > .05). Receiver operating characteristic analysis revealed that C1QC (cutoff: 52.34 μg/dl) and VCAM-1 (cutoff: 431.215 ng/ml) had 78.2% and 66.8% diagnostic accuracy, respectively. Combined detection achieved 80.2% accuracy, surpassing that of carcinoembryonic antigen/carbohydrate antigen 199. Both biomarkers increased with disease progression (P < .05) and aided staging assessment.
Conclusion
Serum C1QC and VCAM-1 demonstrate high diagnostic efficacy in CRC, correlate with pathological features, and hold promise as novel serological screening biomarkers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Graduate College, Hebei North University, 11 Diamond South Road, Zhangjiakou 075000, Hebei Province, China.
- Department of Laboratory Medicine, The First Affiliated Hospital of Hebei North University, 11 Diamond South Road, Zhangjiakou 075000, Hebei Province, China.
- Institute of Oncology, The First Affiliated Hospital of Hebei North University, 11 Diamond South Road, Zhangjiakou 075000, Hebei Province, China.
- First Clinical Medical College, The First Affiliated Hospital of Hebei North University, 11 Diamond South Road, Zhangjiakou 075000, Hebei Province, China.
- Department of General Surgery, The First Affiliated Hospital of Hebei North University, 11 Diamond South Road, Zhangjiakou 075000, Hebei Province, China.
- Tianjin Key Laboratory of Acute Abdomen Disease-Associated Organ Injury and ITCWM Repair, Institute of Integrative Medicine of Acute Abdominal Diseases Tianjin Nankai Hospital, Tianjin Medical University, 8 Changjiang A…
ORCID-Profile: Tian Li
Förderung
- Hebei Province national college students innovation and entrepreneurship training project
- Hebei North University Campus level Cultivation and Research Project
- Graduate Innovation Funding Project in Hebei Province
- Postgraduate Education Project of Hebei North College
- Hebei Provincial Natural Science Precision Medicine Joint Fund Project
Zitieren
APA
Yang, C., Zhang, B., Fan, J., Zhang, Y., Cao, X., Wu, X., & Li, T. (2026). Levels and clinical significance of serum C1QC and VCAM-1 in patients with colorectal cancer or colorectal polyps/adenomas. Postgraduate Medical Journal, 102(1209), 633-644. https://doi.org/10.1093/postmj/qgaf237
Vancouver
Yang C, Zhang B, Fan J, Zhang Y, Cao X, Wu X, et al. Levels and clinical significance of serum C1QC and VCAM-1 in patients with colorectal cancer or colorectal polyps/adenomas. Postgraduate Medical Journal. 2026;102(1209):633-644. doi:10.1093/postmj/qgaf237
BibTeX
@article{Yang2026,
author = {Yang, Chunbaixue and Zhang, Bizhu and Fan, Jianchun and Zhang, Yixuan and Cao, Xinran and Wu, Xueliang and Li, Tian},
title = {Levels and clinical significance of serum C1QC and VCAM-1 in patients with colorectal cancer or colorectal polyps/adenomas},
journal = {Postgraduate Medical Journal},
year = {2026},
volume = {102},
number = {1209},
pages = {633--644},
doi = {10.1093/postmj/qgaf237}
}
EUVIMED